CTOs on the Move

Scanadu

www.scanadu.com

 
Based at NASA-Ames Research Center, Scanadu is using mobile and sensor technology to develop a portfolio of FDA approved, consumer friendly products that put the experience of an emergency room in the palm of your hand. Unveiled in November 2012, the company is working to ensure this is the last generation to know so little about our health. The product portfolio includes the Scanadu Scout vital sign monitor and Scanadu Urine, a urine analysis test. In July 2013, Scanadu became the most funded campaign on Indiegogo, enlisting supporters to be a part of the first usability study, followed by clinical ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.scanadu.com
  • NASA Ames Research Park, Bldg 20
    Moffett Field, CA USA 94035
  • Phone: 408.513.7131

Executives

Name Title Contact Details

Funding

Scanadu raised $35 on 04/28/2015

Similar Companies

Reinhardt Medical Group Inc

Reinhardt Medical Group Inc is a Pensacola, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Chemogen

Chemogen is a South Portland, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Omega Medical Imaging

Omega Medical Imaging is a Sanford, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OXiGENE

OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.

Xycorp Medical

Xycorp Medical Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.